Literature DB >> 7633104

Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis.

R Longo1, P Pollesello, C Ricci, F Masutti, B J Kvam, L Bercich, L S Crocè, P Grigolato, S Paoletti, B de Bernard.   

Abstract

To demonstrate that the lipid volume fraction in liver steatosis can be accurately estimated with in vivo hydrogen-1 magnetic resonance (MR) spectroscopy, the authors developed a calibration procedure based on in vitro MR spectroscopy of lipid extracts from steatotic liver specimens. The lipid volume fractions determined with the calibration procedure were compared with the results of histomorphometry and with calibrated computed tomographic (CT) data. The volume fraction of fat determined with MR spectroscopy was in good agreement with the CT results, whereas histomorphometry underestimated the amount of hepatic fat. The results indicate that determination of the fat volume fraction in steatotic liver can be achieved noninvasively with MR spectroscopy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7633104     DOI: 10.1002/jmri.1880050311

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  103 in total

1.  The effect of short-term fasting on liver and skeletal muscle lipid, glucose, and energy metabolism in healthy women and men.

Authors:  Jeffrey D Browning; Jeannie Baxter; Santhosh Satapati; Shawn C Burgess
Journal:  J Lipid Res       Date:  2011-12-03       Impact factor: 5.922

2.  The utility of Xenon-133 liver scan in the diagnosis and management of nonalcoholic fatty liver disease.

Authors:  Said A Al-Busafi; Peter Ghali; Philip Wong; Javier A Novales-Diaz; Marc Deschênes
Journal:  Can J Gastroenterol       Date:  2012-03       Impact factor: 3.522

3.  Simultaneous assessment of liver volume and whole liver fat content: a step towards one-stop shop preoperative MRI protocol.

Authors:  Gaspard d'Assignies; Claude Kauffmann; Yvan Boulanger; Marc Bilodeau; Valérie Vilgrain; Gilles Soulez; An Tang
Journal:  Eur Radiol       Date:  2010-09-03       Impact factor: 5.315

Review 4.  Quantification of liver fat with magnetic resonance imaging.

Authors:  Scott B Reeder; Claude B Sirlin
Journal:  Magn Reson Imaging Clin N Am       Date:  2010-08       Impact factor: 2.266

5.  In vivo characterization of the liver fat ¹H MR spectrum.

Authors:  Gavin Hamilton; Takeshi Yokoo; Mark Bydder; Irene Cruite; Michael E Schroeder; Claude B Sirlin; Michael S Middleton
Journal:  NMR Biomed       Date:  2010-12-12       Impact factor: 4.044

6.  Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration.

Authors:  Scott B Reeder; Houchun H Hu; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2012-07-06       Impact factor: 4.813

Review 7.  Non-alcoholic fatty liver disease: a diabetologist's perspective.

Authors:  Joseph M Pappachan; Farrah A Antonio; Mahamood Edavalath; Arjun Mukherjee
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

8.  Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis.

Authors:  An Tang; Justin Tan; Mark Sun; Gavin Hamilton; Mark Bydder; Tanya Wolfson; Anthony C Gamst; Michael Middleton; Elizabeth M Brunt; Rohit Loomba; Joel E Lavine; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  Radiology       Date:  2013-02-04       Impact factor: 11.105

Review 9.  Noninvasive imaging assessment of non-alcoholic fatty liver disease: focus on liver scintigraphy.

Authors:  Cristiane Valle Tovo; Angelo Zambam de Mattos; Gabriela Perdomo Coral; Fernanda Schild Branco; Eiji Suwa; Angelo Alves de Mattos
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

10.  Effect of apolipoprotein-B synthesis inhibition on liver triglyceride content in patients with familial hypercholesterolemia.

Authors:  Maartje E Visser; Fatima Akdim; Diane L Tribble; Aart J Nederveen; T Jesse Kwoh; John J P Kastelein; Mieke D Trip; Erik S G Stroes
Journal:  J Lipid Res       Date:  2009-12-14       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.